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Serotype epidemiology and multidrug 
resistance patterns of Salmonella enterica 
infecting humans in Italy
Ilaria Frasson1, Sabrina Bettanello2, Ettore De Canale2, Sara N. Richter1,2* and Giorgio Palù1,2
Abstract 
Background: Salmonella enterica is the zoonotic agent most frequently responsible for foodborne infections in 
humans worldwide. In this work the presence of S. enterica was investigated in 734 unique enteropathogenic isolates 
collected from human patients between 2011 and 2012.
Results: All Salmonella spp. isolates were subjected to serotyping and antimicrobial susceptibility testing. Isolates 
displaying phenotypes and antimicrobial susceptibility profiles different from the reference strains were geno-
tipically characterized. Several plasmid-embedded resistance determinants were identified and characterized. 
Non-typhoidal serotypes were most frequently diagnosed; monophasic Salmonella typhimurium 1,4 [5],12:i- and S. 
typhimurium represented the most prevalent serovars. Five isolates displayed phenotypes with extremely reduced 
susceptibility to antimicrobials: we detected multidrug resistance elements belonging to Ambler class A and class C 
in two non-typhoidal S. enterica serovars, i.e. Rissen and monophasic S. typhimurium 1,4 [5],12:i-, and in one typhoidal 
serovar, i.e., Paratyphi B. These resistance determinants have been so far almost exclusively associated with non-
Salmonella members of the Enterobacteriaceae family. Alarmingly, two colistin resistant Salmonella enteritidis were 
also found.
Conclusions: This work draws the attention to the still low, but rising, percentage of multidrug resistant Salmonella 
isolates infecting humans in Italy. Our results suggest that prompt monitoring of Salmonella serovar dissemination 
and resistance to antimicrobials is highly required.
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Background
Salmonella enterica (S. enterica) consists of more than 
2600 different serovars, which, based on different anti-
gens, are subgrouped into typhoidal and non-typhoidal 
Salmonella (NTS) serovars. These serotypes vary greatly 
in their virulence, natural reservoirs and susceptibility 
to antimicrobials [1]. Typhoidal S. enterica serotypes 
Typhi and Paratyphi A and B infect humans as their 
exclusive reservoirs, causing outbreaks of life-threat-
ening typhoid fever [2]. Outbreaks of typhoid fever are 
mainly restricted to low-income countries, while they 
represent less than 1  % infections in the developed 
countries. In contrast, non-typhoid salmonellosis usu-
ally gives rise to acute but self-resolving gastroenteritis, 
with no need of antimicrobial therapy; life-threatening 
invasive infections may occur in vulnerable patients [3].
In 2015, the European food and safety authority 
(EFSA) reported that the investment of the European 
Union in Salmonella control measures is yielding notice-
able results, with only 20.4 confirmed cases per 100,000 
population. Nevertheless, non-typhoidal salmonello-
sis remains the major cause of foodborne zoonotic out-
breaks [4].
The increasing number of antibiotic-resistant Sal-
monella spp. against first line antimicrobial agents 
(aminopenicillins, trimethorpim-sulfametoxazole and 
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chloramphenicol) intensified the empirical use of fluo-
roquinolones and third generation cephalosporins [5–7]. 
Noticeably, these classes of antibiotics have been recom-
mended for the treatment of Salmonella infections in 
animals [8]. In the last years, retail food, livestock and 
companion animals have been the main sources of NTS 
transmission [9, 10].
Genetic determinants conferring resistance to beta-
lactams and cephalosporins embedded in widely spread-
ing plasmids have been extensively characterized in other 
Enterobacteriaceae, such as E. coli and K. pneumoniae. 
The detailed genetic analysis of circulating plasmids 
helped containing MDR outbreaks [11, 12]. Thus, moni-
toring serovar distribution and antimicrobial resistance 
of S. enterica in humans may be important in controlling 
the infection.
The Microbiology and Virology Unit of the Padua 
Teaching Hospital, National Reference Centre for enter-
opathogenic bacteria and antimicrobial resistance epide-
miology for the Northeast Italy, has begun in 2009 a strict 
surveillance of circulating non-pansusceptible Enterobac-
teriaceae, among which Salmonella spp.
Here we report the phenotypic and genotypic analysis 
of Salmonella isolates infecting human patients between 
January 2011 and December 2012 in Northeast Italy, ana-
lyzed at the Microbiology and Virology Unit of the Padua 
Teaching Hospital. We diagnosed and characterized 
multidrug resistance elements in two non-typhoidal S. 
enterica serovars, Rissen and monophasic typhimurium, 
and in one typhoidal serovar, Paratyphi B. The resistance 
determinants were embedded in plasmids with the abil-
ity to transfer between bacterial species. Two S. enterica 
serotype Enteritidis samples were characterized by colis-
tin resistance.
Methods
Characterization of Salmonella strains: serotyping 
and antimicrobial susceptibility testing
A total of 734 unique enteropathogenic isolates, obtained 
exclusively from human patients, were received and 
characterized by the Microbiology and Virology Unit of 
the  Padua Teaching Hospital. Samples were collected 
between January 2011 and December 2012, according 
to the current version of the Declaration of Helsinki. 
Putative Salmonella containing samples were plated on 
selective xylose lysine deoxycholate agar (XLD agar, Bec-
ton–Dickinson Italia, Milan, Italy) and colonies from 
pure cultures were characterized using a VITEK® 2 auto-
mated system (bioMérieux, Marcy l’Étoile, France). The 
isolates identified as Salmonella spp. were subjected to 
serotyping by slide agglutination, according to the Kauf-
mann-white classification [13].
Antimicrobial susceptibility testing was performed 
on all confirmed Salmonella isolates, by the disc diffu-
sion (Kirby-Bauer) method according to EUCAST crite-
ria [14]. The following antibiotics (μg/disk) were tested 
on Mueller–Hinton agar (Difco Laboratories, Detroit, 
MI), according to Enter-Net specifications: nalidixic 
acid (30), ampicillin (10), cefotaxime (30), ciprofloxacin 
(5), chloramphenicol (30), gentamicin (10), kanamycin 
(30), streptomycin (10), sulphonamide (300), tetracycline 
(30), trimethoprim (5), ampicillin-clavulanic acid (20-
10), cefalotin (30) and sulfamethoxazole-trimethoprim 
(23.75–1.25) (BD BB™ Sensi-Disk™, Becton–Dickinson 
Italia, Milan, Italy). Moreover, the disk diffusion test was 
performed to detect Extended-spectrum beta-lactamases 
(ESBL) (BD BB™ Sensi-Disk™, Becton–Dickinson Italia, 
Milan, Italy).
Colistin susceptibility was determined using Sensititre 
ARIS® 2X (Trek Diagnostic Systems, Thermo Scientific 
Inc., Milan, Italy). Escherichia coli ATCC25922 and E. 
coli ATCC35218 were used as control strains.
Identification of ESBL and AmpC determinants: plasmid 
transfer by transformation and conjugation experiments
Plasmid DNA was obtained from pure bacterial cul-
tures performing phenol/chloroform extraction. Resist-
ance genes (blaTEM, blaSHV, blaCTX-M, and AmpC) were 
detected by PCR as previously described [15, 16]. Posi-
tive PCR products were sequenced in an ABI3130xl 
sequencer (Applied Biosystems, Thermo Scientific Inc., 
Milan, Italy) and sequences were aligned to those present 
in GenBank using BLAST (http://blast.ncbi.nlm.nih.gov/
Blast.cgi).
Plasmids containing PCR-confirmed resistance deter-
minants were introduced into chemo-competent E. coli 
cells (SCSI, Agilent Technologies Italia, Milan, Italy). 
Transformants were plated on selective Mueller–Hinton 
(cefotaxime 2  mg/L or ampicillin 100  mg/L) (Becton–
Dickinson & Co., DifcoTM) agar plates. The presence 
of plasmids was confirmed by PCR targeting the whole 
sequence of the blaTEM/CTX/CMY gene; PCR products 
were treated with exosap and fully sequenced (ABI3130xl 
sequencer, Applied Biosystems). Microbial identification 
and antimicrobial susceptibility testing on transformants 
were performed at a VITEK® two automated system 
(bioMérieux, Marcy l’Étoile, France).
For conjugation experiments, one colony of each donor 
(S. enterica serovars: Rissen, monophasic S. typhimurium 
1,4 [5],12:i- and Paratyphi B) and the recipient strain 
E. coli J53 (F−  met pro Azir Colr) were cultured sepa-
rately under weak agitation in LB broth at 37  °C. Con-
jugation was performed incubating different dilutions 
(from 1:100 to 1:10) of donor suspensions with overnight 
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culture of the recipient strain under low agitation. Mat-
ing assays were carried out at room temperature from 
1  h to overnight depending on the donor strain. The 
transconjugants were selected on agar plates containing 
colistin (8 mg/L) and cefotaxime (2 mg/L) or ampicillin 
(100  mg/L). Microbial identification and antimicrobial 
susceptibility testing on transformants and transconju-
gants were performed by VITEK® two automated system 
(bioMérieux, Marcy l’Étoile, France).
Plasmid PCR‑based replicon typing (PBRT)
All plasmids were analyzed by PCR-based replicon typ-
ing (PBRT) targeting the replicons of the major plasmid 
families occurring in Enterobacteriaceae [17]. Each vec-
tor was assigned to a specific Inc group. Plasmid typing 
was also performed in the obtained transformants and 
transconjugants.
Amplification and analysis of pmrA and pmrB genes
Bacterial total DNA was obtained by heat shock from 
pure culture suspension. PmrA and pmrB genes, the 
major regulators of LPS modifications in S. enterica, 
were amplified as previously described [18]. PCR ampli-
cons were sequenced by end-primers in an ABI3130xl 
sequencer (Applied Biosystems, Thermo Scientific Inc., 
Milan, Italy) and the obtained sequences were compared 
to the corresponding sequences in the NCBI database 
(http://www.ncbi.nlm.nih.gov/nucleotide).
Results
Salmonella enterica serotype distribution and antimicrobial 
susceptibility profiles
The screening of 734 enteropathogenic human speci-
mens yielded identification of 350 S. enterica isolates. 
On the basis of the Kauffmann-White serotyping, three 
samples were positive for typhoidal Salmonella strains: 
two isolates were typed as Salmonella typhi, whereas 
one belonged to the Paratyphi B serovar. The remaining 
99  % samples belonged to different non-typhoidal sero-
vars (NTS). The most common serotypes in the North-
eastern part of Italy were monophasic S. typhimurium 
1,4 [5],12:i- and S. typhimurium, which were retrieved 
in approximately 29.5 and 26.5  % samples, respectively 
(Table  1). The remaining samples belonged predomi-
nantly to S. enteritidis, S. panama and S. napoli; other 
NTS were detected to a minor extent (Table 1).
Antimicrobial susceptibility testing showed that 38.4 % 
of isolates were susceptible to all classes of antibiotics. 
The two Thyphi serovar isolates belonged to this fully 
susceptible group. The remaining Salmonella isolates 
displayed different antimicrobial resistance profiles: (i) 
12.1  % exhibited reduced susceptibility or resistance to 
two classes of antimicrobials; (ii) 13.4  % were classified 
as multidrug-resistant (MDR), i.e. they showed resistance 
against three or more non-structurally related antimi-
crobials; (iii) 36.1 % were resistant to ampicillin, strepto-
mycin, sulphonamides and tetracycline (ASSuT resistant 
pattern). The resistance rate to quinolones and fluoroqui-
nolones (i.e., nalidixic acid and ciprofloxacin) and third 
generation cephalosporins (i.e., cefotaxime, ceftazidime 
and ceftriaxone) was relatively low among the isolates. 
Fluoroquinolones and third generation cephalosporins 
are the antibiotics most widely used in the treatment of 
both human and animal infections. In detail, the isolates 
resistant to nalidixic acid and/or ciprofloxacin were 6 
and 0.5  %, respectively. Reduced susceptibility to third 
generation cephalosporins was detected in 0.9 % isolates. 
Notably, 0.5 % isolates displayed a resistance phenotype 
against fourth generation cephalosporins (i.e., cefepime) 
as well. As reported in other countries, all isolates were 
fully susceptible to imipenem and meropenem [19, 20].
The presence of extended spectrum beta lactamases 
(ESBL) and acquired class C cephalosporinases (AmpC) 
was also investigated by double disk synergy assays. 
Three isolates displayed an ESBL/AmpC phenotype. 
These were further characterized at the molecular level 
to detect plasmid-borne resistance determinants and 
additional resistance mechanisms.
Molecular analysis of resistance determinants  
of ESBL/AmpC producing strains
The three isolates that possessed an ESBL/AmpC pheno-
type belonged to the following serovars: S. paratyphi B, S. 
rissen and monophasic S. typhimurium 1,4 [5],12:i-. Char-
acterization of resistance determinants was performed 
on total bacterial DNA extracted as previously described 
[16, 21]. The major resistance determinants, i.e., blaTEM, 
blaSHV, plasmidic AmpC genes and blaCTX-M-type, were 
Table 1 Serotype ditribution of  Salmonella enterica iso-
lates diagnosed in this study
Serotype % isolates/year
S. typhimurium, monophasic 1,4 [5],,12:i- 29.5
S. typhimurium 26.6
S. enteritidis 9.4
S. panama 5.5
S. napoli 3.2
S. muenchen 1.9
S. derby 1.6
S. thomson 1.2
S. rissen 1.2
S. infantis 1
Others 18
Not determined 0.9
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amplified and sequenced. Genotypic analysis indicated 
that S. paratyphi B harbored blaTEM-52, S. rissen was posi-
tive for blaCMY-2, while monophasic S. typhimurium 1,4 
[5],12:i- encoded blaCTX-M-15.
The detected molecular determinants belonged to 
Ambler Class A and C, which have been previously 
reported within mobile elements in other members of 
the Enterobacteriaceae family, responsible for human 
outbreaks [22]. Therefore, the possible spreading in Sal-
monella of these resistance determinants through highly 
diffusible plasmid was investigated.
Plasmid content of the three isolates was analyzed by 
multiple techniques. Plasmid DNA extractions were ana-
lyzed by PCR: the efficient amplification of the selected 
resistance genes indicated that all determinants con-
ferred plasmid-mediated resistance. For epidemiological 
tracing purposes, backbones were characterized by PCR 
amplification of incompatibility groups to determine 
plasmid replicon typing (PBRT) [17]. This analysis indi-
cated that blaCMY-2 was embedded in an IncA/C plasmid 
and blaTEM-52 in an IncI1-Iγ plasmid. Plasmid analysis of 
the blaCTX-M-15-positive monophasic S. typhimurium 1,4 
[5],12:i- isolate displayed a double replicon profile, i.e. 
IncFIIs and IncFIA, indicating the presence of more than 
one vector or of a backbone with a multi-replicon status.
To confirm plasmid-embedding of the resistance deter-
minants, IncI and IncF plasmids were transformed into E. 
coli and transformants were analyzed for replicon typing 
and for the presence of blaCTX-M-15 and blaTEM-52. Trans-
formation experiments demonstrated that blaCTX-M-15 
was contained in the IncFIA backbone, while no transfor-
mation of the IncFIIs plasmid and blaCMY-2 determinant 
was obtained. Plasmid size or degradation might account 
for the absence of transformants.
Many antibiotic resistance plasmids can promote hori-
zontal dissemination of genetic traits among bacteria of 
different genera through the conjugation process [11]. For 
this reason, transferability of the resistance determinants 
was assessed by mating experiments. All three plasmids 
conjugated successfully: PBRT, along with the presence of 
the three resistance determinants, was confirmed by PCR 
in the recipient E. coli J53 strain. The straightforward 
horizontal transfer of the three backbones suggested that 
both clonal spread and horizontal plasmid transfer may 
have contributed to Salmonella resistance dissemination 
in Salmonella isolates (Table 2).
Colistin susceptibility testing
Because of the recent uprising rate of colistin resistance 
reported in Enterobacteriaceae [23, 24], susceptibility 
to colistin was also evaluated in all Salmonella isolates. 
Indeed, two isolates of S. enterica serotype Enteritidis, 
displayed MIC90 higher than 4  μg/mL and were thus 
considered resistant according to EUCAST breakpoints 
[14]. As mutations in the pmrAB operon were demon-
strated to be involved in Salmonella resistance to colistin 
and other polymixins [18], pmrA and pmrB genes were 
amplified and sequenced. PmrA and pmrB nucleotide 
sequences were identical to those reported for colistin-
susceptible isolates: no polymorphic positions with 
synonymic amino acid substitution, or point nucleotide 
mutation were detected, suggesting the presence of other 
resistance mechanisms responsible for the observed 
reduced susceptibility to colistin [25].
Discussion
Non-typhoidal salmonellosis has not been hitherto con-
sidered a major public health risk in developed countries, 
such as the European Union member states. Up to date, 
only few epidemiology studies on Salmonella isolates 
infecting humans has been published so far [19, 26, 27].
In the present study, we presented the Italian epidemi-
ology of Salmonella isolates infecting humans between 
2011 and 2012, both in terms of serovar distribution and 
in terms of antimicrobial resistance patterns.
Our investigation highlighted that pathogenic Salmo-
nella counted for the majority of all enteropathogenic 
pathogens (47.8 %) diagnosed by our laboratory, National 
Reference Centre for Enteropathogenic Bacteria for the 
Northeast Italy. In the 2-year period of the study, more 
than 11 different serotypes were identified: monophasic 
S. typhimurium 1,4 [5],12:i:- and S. typhimurium were 
the prominent circulating serovars, retrieved in almost 
30 and 27 % of all samples, respectively. In contrast, the 
EFSA report on circulating zoonotic agents in 2013 indi-
cated that S. enteritidis was the most prevalent Salmo-
nella serovar detected in human samples [28].
Our epidemiological data are supported by recent 
works demonstrating that S. typhimurium and mono-
phasic S. typhimurium 1,4 [5],12:i- have extremely high 
survival rates in the environment [29], can infect a broad 
range of species [30] and have enhanced their ability to 
cause salmonellosis in humans [19]. Moreover, these were 
the most common serotypes diagnosed in serious food-
borne salmonellosis outbreaks in both humans and ani-
mals in 2012 [31]. Thus, S. typhimurium and monophasic 
S. typhimurium 1,4 [5],12:i- have to be considered emerg-
ing predominant serotypes in humans all around Europe.
In addition, our study pointed out that 61.6 % of ana-
lyzed Salmonella isolates were resistant to at least one 
antibiotic, with 13.3 % of samples classified as multidrug 
resistant. In accordance with our data, EFSA reported 
increasing multidrug resistance in Salmonella infecting 
humans, where monophasic S. typhimurium 1,4 [5],12:i- 
serotype exhibited the highest rate of multidrug resist-
ance at the European level [32].
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Despite the relatively low resistance rate against the clin-
ically important third generation cephalosporins, molecu-
lar analysis of strains displaying ESBL/AmpC-producing 
phenotypes proved that the isolates bore worrisome plas-
mid-embedded resistance determinants, able to move 
through bacterial species: AmpC, such as CMY-2, and 
ESBL, such as TEM-52 and CTX-M-15. The three deter-
minants have been more commonly associated with other 
members of the Enterobacteriaceae family [33]. Notably, 
the identified genes have been recently reported in human 
outbreaks of salmonellosis all around the world [19, 20, 
34], associated with other Salmonella serovars and embed-
ded in plasmids distinct from the ones traced in this study.
So far, ESBL have been rarely described in S. paratyphi 
B at the European level and have been never reported 
at the Italian level [35, 36]. Moreover, Salmonella sero-
type Rissen is a widespread contaminant of pigs and pork 
products [37] and up to date the presence of CMY-like 
cephalosporinases in this serovar had been reported only 
in South Korea in 2002 [38, 39]. Our data highlight the 
possible future spreading of resistance to first line antimi-
crobials through this serovar.
An additional worrisome feature described here is 
the detection of two isolates of S. enteritidis display-
ing resistance to colistin. In Europe, S. enteritidis is 
reported to be one of the most frequent serotypes diag-
nosed both in animals and in humans. No other studies 
detected and characterized, up to date, colistin-resistant 
isolates belonging to this serovar. Up to 2013, the high-
est proportions of resistance among S. enteritidis isolates 
were observed for nalidixic acid (19.5  %) and ampicil-
lin (11.0  %), while resistance to third generation cepha-
losporins was generally detected at low levels [32]. 
The spreading of colistin-resistant S. enteritidis could 
worsen the clinical treatment of life-threatening cases of 
salmonellosis.
Conclusions
Our results provide an outline of serotype distribution 
and rising antibiotic resistance among S. enterica causing 
salmonellosis in humans in Italy. The serotype landscape 
differs from the one presented by the EFSA reports and 
deserves to be further monitored.
The described plasmid-embedded resistance determi-
nants circulating in Salmonella serovars should be closely 
surveilled, as they could possibly become a public health 
threat, as occurred in the last years for others Enterobac-
teriaceae, such as K. pneuomoniae [12, 22, 24, 33].
Abbreviations
S. enterica: Salmonella enterica; NTS: non-typhoidal Salmonella; EFSA: European 
food and safety authority; E. coli: Escherichia coli; K. pneumoniae: Klebsiella pneu-
moniae; Azir Colr: sodium azide resistant and colistin resistant; ESBL: extended-
spectrum beta-lactamases; PBRT: PCR-based replicon typing; MDR: multidrug 
resistant; ASSuT: ampicillin, streptomycin, sulfonamides, and tetracycline.
Table 2 Characteristics of ESBL or AmpC-positive Salmonella isolates and transformed or transconjugated E. coli isolates 
analyzed in this study
AMX amoxicillin; CFPM cefepime; CAZ ceftazidime; CTX cefotaxime; FOX cefoxitin; KAN kanamycin; GEN gentamicin; STR streptomycin; SMX sulfamethoxazole; TET 
tetracycline; TMP trimethoprim; nd  not detected
Serovar Antimicrobial susceptibility testing ASSuT PCR PBRT
AMX (mg/L) CFPM (mg/L) CAZ (mg/L) CTX (mg/L) FOX  
(diameter 
zone)
Additional 
resistances
S. rissen >8 ≤1 >4 ≥2 7 mm GEN, STR, STX, 
TET
Positive blaCMY-2 IncA/C
monophasic S. 
typhimurium 
(1,4,[5],12:i:-)
>8 ≥4 >4 ≥2 26 mm KAN, GEN, STR, 
STX, TET, TMP
Positive blaCTX-M-15 IncFIA, IncFIIS
S. Paratyphi B >8 ≥4 >4 ≥2 26 mm nd Negative blaTEM-52 I1-Ig
E. coli trans-
formed  
blaCTX-M-15
>8 ≥4 >4 ≥2 – nd nd blaCTX-M-15 IncFIA
E. coli trans-
formed 
blaTEM-52
>8 ≥4 >4 ≥2 – nd nd blaTEM-52 I1-Ig
E. coli J53 
blaCMY-2
>8 ≤1 >4 ≥2 – nd nd blaCMY-2 IncA/C
E. coli J53  
blaCTX-M-15
>8 ≥4 >4 ≥2 – nd nd blaCTX-M-15 IncFIA
E. coli J53 
blaTEM-52
>8 ≥4 >4 ≥2 – nd nd blaTEM-52 I1-Ig
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